Mutational analysis of the müllerian-inhibiting substance gene and its receptor gene in Japanese women with polycystic ovary syndrome and premature ovarian failure

Fertility and Sterility

Volumn 78, Issue 6, 2002, Pages 1329-1330

  Wang, Hua Qin ^a   Takakura, Kenji ^a   Takebayashi, Koichi ^a   Noda, Yoichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GENOMIC DNA; GONADOTROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PRIMER DNA;

ADULT; AGAR GEL ELECTROPHORESIS; AMENORRHEA; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC DAMAGE; GENETIC VARIABILITY; GONADOTROPIN BLOOD LEVEL; HUMAN; KARYOTYPE 46,XX; LETTER; LEUKOCYTE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUELLERIAN INHIBITING FACTOR GENE; OLIGOMENORRHEA; ONSET AGE; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; POINT MUTATION; POLYMERASE CHAIN REACTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0036901677     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04351-0     Document Type: Article

References (9)

1. Cate R.L., Mattaliano R.J., Hession C., Tizard R., Farber N.M., Cheung A., et al. Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells. Cell. 45:1986;685-698.
2. Rajpert-De Meyts E., Jørgensen N., Græm N., Muller J., Cate R.L., Skakkebæk N.E. Expression of anti-müllerian hormone during normal and pathological gonadal development association with differentiation of Sertoli and granulosa cells . J Clin Endocrinol Metab. 84:1999;3836-3844.
3. Takahashi M., Koide S.S., Donahoe P.K. Müllerian inhibiting substance as oocyte meiosis inhibitor. Mol Cell Endocrinol. 47:1986;225-234.
4. Ueno S., Manganaro T.F., Donahoe P.K. Human recombinant müllerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro. Endocrinology. 123:1988;1652-1659.
5. Durlinger A.L.L., Kramer P., Karels B., de Jong F.H., Uilenbroek J.T.J., Grootegoed J.A., et al. Control of primordial follicle recruitment by anti-müllerian hormone in the mouse ovary. Endocrinology. 140:1999;5789-5796.
6. Imbeaud S., Faure E., Lamarre I., Mattei M.G., di Clemente N., Tizard R., et al. Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor. Nature Genet. 11:1995;382-388.
7. Baarends W.M., Uilenbroek J.T.J., Kramer P., Hoogerbrugge J.W., van Leeuwen E.C., Themmen A.P., et al. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 136:1995;4951-4962.
8. Takebayashi K., Takakura K., Wang H.-Q., Kimura F., Kasahara K., Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril. 74:2000;976-979.
9. Imbeaud S., Carre-Eusebe D., Rey R., Belville C., Josso N., Picard J.-Y. Molecular genetics of the persistent müllerian duct syndrome a study of 19 families . Hum Mol Genet. 3:1994;125-131.